BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8413772)

  • 1. An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs.
    Izumotani T; Ishimura E; Tsumura K; Goto K; Nishizawa Y; Morii H
    Nephron; 1993; 65(1):137-40. PubMed ID: 8413772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chinese herbs-induced renal failure with Fanconi syndrome: a report of 6 cases].
    Yu Y; Zheng FL; Li H
    Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):110-2. PubMed ID: 12783708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraquat-induced Fanconi syndrome.
    Gil HW; Yang JO; Lee EY; Hong SY
    Nephrology (Carlton); 2005 Oct; 10(5):430-2. PubMed ID: 16221089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult onset Fanconi syndrome: extensive tubulo-interstitial lesions and glomerulopathy in the early stage of Chinese herbs nephropathy.
    Kazama I; Matsubara M; Michimata M; Suzuki M; Hatano R; Sato H; Ito S
    Clin Exp Nephrol; 2004 Sep; 8(3):283-7. PubMed ID: 15480910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual cause of hypokalemic paralysis: aristolochic acid nephropathy with Fanconi syndrome.
    Tsai CS; Chen YC; Chen HH; Cheng CJ; Lin SH
    Am J Med Sci; 2005 Sep; 330(3):153-5. PubMed ID: 16175002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubular disturbances induced by tributyl-tin oxide in guinea pigs: a secondary Fanconi syndrome.
    Mori Y; Iesato K; Ueda S; Mori T; Iwasaki I; Ohnishi K; Seino Y; Wakashin Y; Wakashin M; Okuda K
    Clin Nephrol; 1984 Feb; 21(2):118-25. PubMed ID: 6723111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis.
    Yang SS; Chu P; Lin YF; Chen A; Lin SH
    Am J Kidney Dis; 2002 Mar; 39(3):E14. PubMed ID: 11877594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis.
    Min HK; Kim EO; Lee SJ; Chang YK; Suh KS; Yang CW; Kim SY; Hwang HS
    BMC Nephrol; 2013 Jan; 14():13. PubMed ID: 23320835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two case studies from a family with primary Fanconi syndrome.
    Wen SF; Friedman AL; Oberley TD
    Am J Kidney Dis; 1989 Mar; 13(3):240-6. PubMed ID: 2919605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of human proximal tubular transport defects.
    Gonick HC
    Klin Wochenschr; 1982 Oct; 60(19):1201-11. PubMed ID: 6292569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid.
    Lee S; Lee T; Lee B; Choi H; Yang M; Ihm CG; Kim M
    Nephrology (Carlton); 2004 Jun; 9(3):126-9. PubMed ID: 15189173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximal Renal Tubular Acidosis (Fanconi Syndrome) Induced by Apremilast: A Case Report.
    Perrone D; Afridi F; King-Morris K; Komarla A; Kar P
    Am J Kidney Dis; 2017 Nov; 70(5):729-731. PubMed ID: 28823583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fever of unknown origin as the initial manifestation of valproate-induced Fanconi syndrome.
    Nozaki F; Kumada T; Kusunoki T; Fujii T; Murayama K; Ohtake A
    Pediatr Neurol; 2014 Dec; 51(6):846-9. PubMed ID: 25439492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate.
    Yamazaki S; Watanabe T; Sato S; Yoshikawa H
    Pediatr Int; 2016 Oct; 58(10):1023-1026. PubMed ID: 26896192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.
    Rossi R; Helmchen U; Schellong G
    Eur J Pediatr; 1992 May; 151(5):384-7. PubMed ID: 1396897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Fanconi Syndrome in a Patient with Nontyphoidal Salmonella Bacteremia.
    Ryuge A; Saito S; Morioka H; Hachiya A; Kato N; Ishimoto T; Kosugi T; Maruyama S
    Intern Med; 2021 Mar; 60(5):761-764. PubMed ID: 32999244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab.
    Shaikh A; Wiisanen ME; Gunderson HD; Leung N
    Ann Pharmacother; 2009 Jul; 43(7):1370-3. PubMed ID: 19584382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fanconi syndrome of cystinosis: insights into the pathophysiology.
    Sakarcan A
    Turk J Pediatr; 2002; 44(4):279-82. PubMed ID: 12458800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic Acid-Associated Fanconi Syndrome in Patients With Cancer.
    Portales-Castillo I; Mount DB; Nigwekar SU; Yu EW; Rennke HG; Gupta S
    Am J Kidney Dis; 2022 Oct; 80(4):555-559. PubMed ID: 35219759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced Fanconi syndrome in patients with kidney allograft transplantation.
    Tang Z; Li T; Dai H; Feng C; Xie X; Peng F; Lan G; Yu S; Wang Y; Fang C; Nie M; Yuan X; Tang X; Jiang X; Zhu X; Fan Y; Peng J; Sun S; Zhong M; Zhang H; Peng L
    Front Immunol; 2022; 13():979983. PubMed ID: 36059468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.